Palliare
For a new era of laparoscopic, endoluminal, endoscopic and robotic surgery.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $8.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Notes (0)
More about Palliare
EditPalliare is dedicated to advancing the state-of-the-art in smoke evacuation and insufflation technologies for laparoscopic, endoluminal, endoscopic, colorectal, and robotic surgery.
With distinct solutions for surgery and endoscopy, Palliare is paving the way to safer operating suites with products that provide exceptional smoke evacuation, consistent, controlled pressure, and hands-free activation.
Palliare is a privately funded company, founded in 2018 as a spin-off from gastro-diagnostic company Crospon, which was acquired by Medtronic (NYSE:MDT) in 2017 and has offices in Oceanside, CA, and Galway, Ireland.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads